Effective Dose of Ramosetron for Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Patients

Table 3

Rhodes index of nausea, vomiting, and retching (RINVR) and incidence of complete responses.

	Group A; (N = 16)	Group B; (N = 16)	Group C; (N = 15)
During 0~1 hr
Complete responses	12 (75%)	9 (56%)	13 (87%)
Occurrence score	0.71 ± 1.16	0.82 ± 1.01	0.41 ± 0.94
Distress score	0.82 ± 1.81	0.71 ± 0.99	0.35 ± 0.86
Experience score	1.53 ± 2.81	1.53 ± 1.94	0.81 ± 1.80
During 1~6 hrs
Complete responses	13 (81%)	10 (63%)	12 (80%)
Occurrence score	0.76 ± 1.92	1.00 ± 1.58	0.53 ± 1.23
Distress score	0.65 ± 1.97	0.65 ± 1.11	0.29 ± 0.69
Experience score	1.50 ± 3.92	1.80 ± 2.72	0.88 ± 1.96
During 6~24 hrs
Complete responses	7 (44%)	13 (81%)	14 (93%)
Occurrence score	2.12 ± 2.74	1.18 ± 3.09	0.53 ± 1.74
Distress score	1.59 ± 2.50	0.94 ± 2.77	0.24 ± 0.75
Experience score	3.94 ± 5.25	2.25 ± 5.98	0.81 ± 2.56
During 24~48 hrs
Complete responses	14 (88%)	13 (81%)	14 (93%)
Occurrence score	0.47 ± 1.33	0.65 ± 1.54	0.47 ± 1.50
Distress score	0.35 ± 1.22	0.65 ± 1.66	0.29 ± 0.99
Experience score	0.88 ± 2.50	1.38 ± 3.26	0.81 ± 2.56

as compared with group A.
The values are shown as means ± SD or proportions of patients (%).